ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

AVBP ArriVent BioPharma Inc

18.70
-0.13 (-0.69%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2023Mar 2024
USD ($)USD ($)
Total Revenue 00
Operating Income -23.12M-20.67M
Pre Tax Income -21.19M-17.42M
Net Income -21.19M-17.42M
Preferred Dividends 00
Basic Earnings Per Share (EPS) 00
EBIT -23.12M-20.67M
EBITDA -23.12M-20.67M
Year End December 30 2023 20222023
USD ($)USD ($)
Total Revenue 00
Operating Income -36.91M-74.59M
Pre Tax Income -36.91M-69.33M
Net Income -36.91M-69.33M
Preferred Dividends 00
Basic Earnings Per Share (EPS) -0.125-0.231
EBIT -36.91M-74.59M
EBITDA -36.91M-74.59M

Your Recent History

Delayed Upgrade Clock